+TIP EB1 downregulates paclitaxel-induced proliferation inhibition and apoptosis in breast cancer cells through inhibition of paclitaxel binding on microtubules

International Journal of Oncology

Volumn 46, Issue 1, 2015, Pages 133-146

  Thomas, Geethu Emily ^a   Sreeja, Jamuna S ^a   Gireesh, K K ^a   Gupta, Hindol ^a   Manna, Tapas K ^a  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

Apoptosis; EB1; Microtubule; P53; Paclitaxel

Indexed keywords

MAPRE1 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; PACLITAXEL; SMALL INTERFERING RNA;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; BREAST TUMOR; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; GENETICS; HUMAN; MCF 7 CELL LINE; METABOLISM; MICROTUBULE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MCF-7 CELLS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; PACLITAXEL; RNA, SMALL INTERFERING;

EID: 84917734762     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2701     Document Type: Article

References (60)

1. Kamangar F, Dores GM and Anderson WF : Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographical regions of the world. J Clin Oncol 24: 2137-2150, 2006.
2. Mamounas EP, Bryant J, Lembersky B, Fehrenbacher L, Sedlacek SM, Fisher B, Wickerham DL, Yothers G, Soran A and Wolmark N: Paclitaxel after doxorubicin and cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. J Clin Oncol 23: 3686-3696, 2005.
3. Martin M, Seguí MA, Antón A, Ruiz A, Ramos M, Adrover E, Aranda I, Rodriguez-L escure A, Grosse R, Calvo L, et al; GEICA M 9805 Investigators: Adjuvant docetaxel for high-risk, node-negative breast cancer. N Engl J Med 363: 2200-2210, 2010.
4. Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, et al: Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 21: 976-983, 2003.
5. McGrogan BT, Gilmartin B, Carney DN and McCann A: Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta 1785: 96-132, 2008.
6. Jordan MA and Wilson L: Microtubules as a target for anticancer drugs. Nat Rev Cancer 4: 253-265, 2004.
7. Manfredi JJ, Parness J and Horwitz SB: Taxol binds to cellular microtubules. J Cell Biol 94: 688-696, 1982.
8. Giannakakou P, Gussio R, Nogales E, Downing KH, Zaharevitz D, Bollbuck B, Poy G, Sackett D, Nicolaou KC and Fojo T: A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc Natl Acad Sci USA 97: 2904-2909, 2000.
9. Orr GA, Verdier-Pinard P, McDaid H and Horwitz SB: Mechanisms of Taxol resistance related to microtubules. Oncogene 22: 7280-7295, 2003.
10. Kavallaris M, Kuo DY, Burkhart CA, Regl DL, Norris MD, Haber M and Horwitz SB: Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J Clin Invest 100: 1282-1293, 1997.
11. Derry WB, Wilson L and Jordan MA: Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry 34: 2203-2211, 1995.
12. Jordan MA, Toso RJ, Thrower D and Wilson L: Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90: 9552-9556, 1993.
13. Blagosklonny MV, Robey R, Sheikh MS and Fojo T: Paclitaxel-induced FasL- independent apoptosis and slow (non-apoptotic) cell death. Cancer Biol Ther 1: 113-117, 2002.
14. Ganguly A, Yang H, Pedroza M, Bhattacharya R and Cabral F: Mitotic centromere-associated kinesin (MCA K) mediates paclitaxel resistance. J Biol Chem 286: 36378-36384, 2011.
15. Sung M and Giannakakou P: BRCA 1 regulates microtubule dynamics and taxanes-induced apoptotic cell signaling. Oncogene 33: 1418-1428, 2014.
16. Wang H, Liu B, Zhang C, Peng G, Liu M, Li D, Gu F, Chen Q, Dong JT, Fu L and Zhou J: Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule-dependent mechanism. J Pathol 218: 76-85, 2009.
17. Alli E, Bash-Babula J, Yang JM and Hait WN : Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 62: 6864-6869, 2002.
18. Sun X, Li D, Yang Y, Ren Y, Li J, Wang Z, Dong B, Liu M and Zhou J: Microtubule-binding protein CLI P-170 is a mediator of paclitaxel sensitivity. J Pathol 226: 666-673, 2012.
19. Lu Q and Luduena RF: Removal of beta III isotype enhances taxol induced microtubule assembly. Cell Struct Funct 18: 173-182, 1993.
20. Kamath K, Wilson L, Cabral F and Jordan MA: Beta-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability. J Biol Chem 280: 12902-12907, 2005.
21. Akhmanova A and Steinmetz MO: Tracking the ends: a dynamic protein network controls the fate of microtubule tips. Nat Rev Mol Cell Biol 9: 309-322, 2008.
22. Honnappa S, Okhrimenko O, Jaussi R, Jawhari H, Jelesarov I, Winkler FK and Steinmetz MO: Key interaction modes of dynamic +TI P networks. Mol Cell 23: 663-671, 2006.
23. Komarova Y, Lansbergen G, Galjart N, Grosveld F, Borisy GG and Akhmanova A: EB1 and EB3 control CLI P dissociation from the ends of growing microtubules. Mol Biol Cell 16: 5334-5345, 2005.
24. Askham JM, Vaughan KT, Goodson HV and Morrison EE : Evidence that an interaction between EB1 and p150(Glued) is required for the formation and maintenance of a radial microtubule array anchored at the centrosome. Mol Biol Cell 13: 3627-3645, 2002.
25. Dixit R, Barnett B, Lazarus JE, Tokito M, Goldman YE and Holzbaur EL : Microtubule plus-end tracking by CLI P-170 requires EB1. Proc Natl Acad Sci USA 106: 492-497, 2009.
26. Su LK and Qi Y: Characterization of human MAPRE genes and their proteins. Genomics 71: 142-149, 2001.
27. Tirnauer JS, Grego S, Salmon ED and Mitchison TJ : EB1-microtubule interactions in Xenopus egg extracts: role of EB1 in microtubule stabilization and mechanisms of targeting to microtubules. Mol Biol Cell 13: 3614-3626, 2002.
28. Manna T, Honnappa S, Steinmetz MO and Wilson L: Suppression of microtubule dynamic instability by the +TI P protein EB1 and its modulation by the CA P-G ly domain of p150glued. Biochemistry 47: 779-786, 2008.
29. Vitre B, Coquelle FM, Heichette C, Garnier C, Chrétien D and Arnal I: EB1 regulates microtubule dynamics and tubulin sheet closure in vitro. Nat Cell Biol 10: 415-421, 2008.
30. Komarova Y, De Groot CO, Grigoriev I, Gouveia SM, Munteanu EL, Schober JM, Honnappa S, Buey RM, Hoogenraad CC, Dogterom M, et al: Mammalian end binding proteins control persistent microtubule growth. J Cell Biol 184: 691-706, 2009.
31. Mohan R, Katrukha EA, Doodhi H, Smal I, Meijering E, Kapitein LC, Steinmetz MO and Akhmanova A: End-binding proteins sensitize microtubules to the action of microtubule-targeting agents. Proc Natl Acad Sci USA 110: 8900-8905, 2013.
32. Maurer SP, Cade NI, Bohner G, Gustafsson N, Boutant E and Surrey T: EB1 accelerates two conformational transitions important for microtubule maturation and dynamics. Curr Biol 24: 372-384, 2014.
33. Draviam VM, Shapiro I, Aldridge B and Sorger PK: Misorientation and reduced stretching of aligned sister kinetochores promote chromosome missegregation in EB1- or APC- depleted cells. EMBO J 25: 2814-2827, 2006.
34. Bruning-R ichardson A, Langford KJ, Ruane P, Lee T, Askham JM and Morrison EE : EB1 is required for spindle symmetry in mammalian mitosis. PLoS One 6: e28884, 2011.
35. Ward T, Wang M, Liu X, Wang Z, Xia P, Chu Y, Wang X, Liu L, Jiang K, Yu H, et al: Regulation of a dynamic interaction between two microtubule-binding proteins, EB1 and TI P150, by the mitotic p300/CBP-associated factor (PCAF ) orchestrates kinetochore microtubule plasticity and chromosome stability during mitosis. J Biol Chem 288: 15771-15785, 2013.
36. Green RA, Wollman R and Kaplan KB: APC and EB1 function together in mitosis to regulate spindle dynamics and chromosome alignment. Mol Biol Cell 16: 4609-4622, 2005.
37. Sun L, Gao J, Dong X, Liu M, Li D, Shi X, Dong J, Lu X, Liu C and Zhou J: EB1 promotes Aurora-B kinase activity through blocking its inactivation by protein phosphatase 2A. Proc Natl Acad Sci USA 105: 7153-7158, 2008.
38. Dong X, Liu F, Sun L, Liu M, Li D, Su D, Zhu Z, Dong JT, Fu L and Zhou J: Oncogenic function of microtubule end-binding protein 1 in breast cancer. J Pathol 220: 361-369, 2010.
39. Jaïs P, Sabourin JC, Bombled J, Rougier P, Lasser P, Duvillard P, Bénard J and Bressac-de Paillerets B: Absence of somatic alterations of the EB1 gene adenomatous polyposis coli-associated protein in human sporadic colorectal cancers. Br J Cancer 78: 1356-1360, 1998.
40. Nishigaki R, Osaki M, Hiratsuka M, Toda T, Murakami K, Jeang KT, Ito H, Inoue T and Oshimura M: Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics 5: 3205-3213, 2005.
41. Wang Y, Zhou X, Zhu H, Liu S, Zhou C, Zhang G, Xue L, Lu N, Quan L, Bai J, et al: Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC ) may promote cellular growth by activating beta-catenin/TCF pathway. Oncogene 24: 6637-6645, 2005.
42. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF and Brooks SC: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-Cancer Res 50: 6075-6086, 1990.
43. Kittler R, Heninger AK, Franke K, Habermann B and Buchholz F: Production of endoribonuclease-prepared short interfering RNA s for gene silencing in mammalian cells. Nat Methods 2: 779-784, 2005.
44. Calegari F, Haubensak W, Yang D, Huttner WB and Buchholz F: Tissue-specific RNA interference in post-implantation mouse embryos with endoribonuclease-prepared short interfering RNA . Proc Natl Acad Sci USA 99: 14236-14240, 2002.
45. Manna T, Thrower DA, Honnappa S, Steinmetz MO and Wilson L: Regulation of microtubule dynamic instability in vitro by differentially phosphorylated stathmin. J Biol Chem 284: 15640-15649, 2009.
46. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
47. Zhang L, Lau YK, Xia W, Hortobagyi GN and Hung MC: Tyrosine kinase inhibitor emodin suppresses growth of HER- 2/neu-overexpressing breast cancer cells in athylic mice and sensitizes these cells to the inhibitory effects of paclitaxel. Clin Cancer Res 5: 343-353, 1999.
48. Gireesh KK, Rashid A, Chakraborti S, Panda D and Manna T: CIL- 102 binds to tubulin at colchicine binding site and triggers apoptosis in MCF- 7 cells by inducing monopolar and multinucleated cells. Biochem Pharmacol 84: 633-645, 2012.
49. Young A, Dictenberg JB, Purohit A, Tuft R and Doxsey SJ: Cytoplasmic dynein-mediated assembly of pericentrin and gamma tubulin onto centrosomes. Mol Biol Cell 11: 2047-2056, 2000.
50. Ciardiello F, Caputo R, Pomatico G, De Laurentiis M, De Placido S, Bianco AR, Tortora G: Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF- 10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type - protein kinase A. Int J Cancer 85: 710-715, 2000.
51. Giannakakou P, Sackett DL, Ward Y, Webster KR, Blagosklonny MV and Fojo T: p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol 2: 709-717, 2000.
52. Luo Y, Li D, Ran J, Yan B, Chen J, Dong X, Liu Z, Liu R, Zhou J and Liu M: End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability. Protein Cell 5: 469-479, 2014.
53. Skube SB, Chaverri JM and Goodson HV: Effect of GF P tags on the localization of EB1 and EB1 fragments in vivo. Cytoskeleton (Hoboken) 67: 1-12, 2010.
54. Giannakakou P, Nakano M, Nicolaou KC, O'Brate A, Yu J, Blagosklonny MV, Greber UF and Fojo T: Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc Natl Acad Sci USA 99: 10855-10860, 2002.
55. Rathinasamy K and Panda D: Kinetic stabilization of microtubule dynamic instability by benomyl increases the nuclear transport of p53. Biochem Pharmacol 76: 1669-1680, 2008.
56. Carney BK, Caruso Silva V and Cassimeris L: The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53. Cytoskeleton (Hoboken) 69: 278-289, 2012.
57. Tao W, South VJ, Zhang Y, Davide JP, Farrell L, Kohl NE, Sepp-L orenzino L and Lobell RB: Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell 8: 49-59, 2005.
58. Maurer SP, Fourniol FJ, Bohner G, Moores CA and Surrey T: EBs recognize a nucleotide dependent structural cap at growing microtubule ends. Cell 149: 371-382, 2012.
59. Sandblad L, Busch KE, Tittmann P, Gross H, Brunner D and Hoenger A: The Schizosaccharomyces pombe EB1 homolog Mal3p binds and stabilizes microtubule lattice seam. Cell 127: 1415-1424, 2006.
60. Pagano A, Honoré S, Mohan R, Berges R, Akhmanova A and Braguer D: Epothilone B inhibits migration of glioblastoma cells by inducing microtubule catastrophes and affecting EB1 accumulation at microtubule plus ends. Biochem Pharmacol 84: 432-443, 2012.